البلد: بلجيكا
اللغة: الإنجليزية
المصدر: AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)
Drospirenone 3 mg (pink tablet); Ethinylestradiol 0,02 mg (pink tablet); Placebo (white tablet)
Sandoz SA-NV
G03AA12
Ethinylestradiol; Drospirenone; Placebo
0,02 mg - 3 mg
Film-coated tablet
Ethinylestradiol 0.02 mg; Drospirenone 3 mg; Placebo
Oral use
Drospirenone and Ethinylestradiol
CTI code: 426982-01 - Pack size: 28 (24 + 4) - Commercialisation status: NO - Delivery mode: Medical prescription; CTI code: 426982-04 - Pack size: 13 x 28 (24 + 4) - Commercialisation status: NO - FMD code: 07613421000714 - CNK code: 2985265 - Delivery mode: Medical prescription; CTI code: 426982-02 - Pack size: 3 x 28 (24 + 4) - Commercialisation status: YES - FMD code: 07613421000721 - CNK code: 2985273 - Delivery mode: Medical prescription; CTI code: 426982-03 - Pack size: 6 x 28 (24 + 4) - Commercialisation status: YES - FMD code: 07613421000707 - CNK code: 2985281 - Delivery mode: Medical prescription
Commercialised: Yes
2012-09-10